Smoking Clinical Trial
Official title:
Development of a Combined Screening and Intervention Program for Emergency Department Patients Who Both Drink and Smoke
Verified date | June 2020 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Smoking and drinking are two of the three leading causes of preventable deaths in the United
States today. Using both alcohol and tobacco significantly multiplies the risk of disease and
death from myocardial infarction, COPD, and multiple cancers. Combined use of these
substances is extremely common; people who drink are three times more likely than the general
population to smoke, and tobacco dependent individuals are four times more likely than the
general population to be alcohol-dependent.
Research has shown that there is a high prevalence of unmet substance abuse treatment need
among adult Emergency Department (ED) patients. The current project aims to conduct a pilot
feasibility study with 50 adult ED patients to develop a brief counseling intervention that
is feasible and acceptable to patients who are both smokers and at-risk drinkers to help them
reduce these behaviors.
The overarching aim of this line of research is to find the best treatment for ED patients
who are combo smokers and at-risk drinkers. The study will focus on the development of an
intervention that will be tested in a future larger scale randomized clinical trial.
Status | Completed |
Enrollment | 50 |
Est. completion date | May 8, 2014 |
Est. primary completion date | May 8, 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adults = or > 18 years old - English speaking - Willing and able to give informed consent - Current daily smoker - Smokes 5 or more cigarettes daily - Alcohol screening score =/> than 8 and =< 19 Exclusion Criteria: - Too ill to consent - Not interested in quitting drinking and smoking - Current use of smoking / alcohol use cessation medications / products - Current involvement in alcohol or smoking treatment program - Doe not have locator information |
Country | Name | City | State |
---|---|---|---|
United States | Yale New Haven Hospital Emergency Department | New Haven | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Yale University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Areas in need of help | Descriptive summary of patient reports of areas in need of help as reported during assessments | 3 months | |
Primary | Barriers and facilitators to accessing care | Descriptive summary of patient reports of barriers and facilitators encountered in trying to access needed alcohol and smoking cessation treatments | 3 months | |
Primary | Counseling satisfaction | Patient reports of satisfaction with counseling modules delivered | 3 months | |
Secondary | Treatment utilization | Number of contacts with treatment resources for alcohol and tobacco cessation | 3 months | |
Secondary | Reduction of consumption | Patient self reported reductions in smoking and drinking | 3 months | |
Secondary | Quit attempts | Number of quit attempts (smoking and drinking) | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02649556 -
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Completed |
NCT03305978 -
Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.
|
N/A | |
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Active, not recruiting |
NCT02752022 -
Monitoring the Transition From Smoking to E-cigarettes
|
||
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02901171 -
The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation
|
N/A | |
Completed |
NCT04340830 -
The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants
|
N/A | |
Completed |
NCT02912000 -
TEACH: Technology Evaluation to Address Child Health
|
N/A | |
Completed |
NCT02949648 -
Electronic Cigarette Use and Quitting in Youth
|
N/A | |
Completed |
NCT02945371 -
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
|
N/A | |
Completed |
NCT02246114 -
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
|
N/A | |
Completed |
NCT01954407 -
Young Adults' Responses to Anti-smoking Messages
|
N/A | |
Completed |
NCT02008292 -
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
|
N/A | |
Completed |
NCT01898507 -
Nicotine Metabolism and Low Nicotine Cigarettes
|
N/A |